Heartline Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 04-10-2024
- Paid Up Capital ₹ 1.81 M
as on 04-10-2024
- Company Age 26 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.75 M
as on 04-10-2024
- Revenue 11.17%
(FY 2020)
- Profit 66.16%
(FY 2020)
- Ebitda 164.96%
(FY 2020)
- Net Worth 12.35%
(FY 2020)
- Total Assets 12.19%
(FY 2020)
About Heartline Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 1.81 M.
The company currently has active open charges totaling ₹0.75 M.
Ravindra Harshe, Prasad Deshmukh, Shaila Kapre, and Nine other members serve as directors at the Company.
- CIN/LLPIN
U85110MH1998PTC114710
- Company No.
114710
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Satara, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Heartline Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shaila Kapre  | Managing Director | 21-Aug-2004 | Current |
Board Members(11)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravindra Harshe | Director | 10-Apr-2010 | Current |
| Prasad Deshmukh | Director | 09-May-1998 | Current |
| Sanjay Korde | Director | 10-Apr-2010 | Current |
| Ramesh Patil | Director | 16-Sep-2006 | Current |
| Umesh Pingale | Director | 21-Aug-2004 | Current |
| Anant Sathe | Director | 09-May-1998 | Current |
Financial Performance of Heartline Diagnostics.
Heartline Diagnostics Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 11.17% increase. The company also saw a substantial improvement in profitability, with a 66.16% increase in profit. The company's net worth Soared by an impressive increase of 12.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Heartline Diagnostics?
In 2020, Heartline Diagnostics had a promoter holding of 41.35% and a public holding of 58.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Symbiosis Hospital And Research Centre Private LimitedActive 24 years 6 monthsPrasad Deshmukh and Shaila Kapre are mutual person
- Sanjeevan C T Scan Centre Private LimitedActive 26 years 22 days
Sanjay Korde and Suresh Chavan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karad Urban Co-Operative Bank Limited Creation Date: 28 May 2008 | ₹0.50 M | Open |
Dhanwantaei Nagaei Patsanstha Creation Date: 18 Oct 2005 | ₹0.25 M | Open |
How Many Employees Work at Heartline Diagnostics?
Unlock and access historical data on people associated with Heartline Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Heartline Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heartline Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
